Optimal Assessment of Metastatic Breast Carcinoma: The Value of Cytopathology Combined with Molecular Analysis

Optimal Assessment of Metastatic Breast Carcinoma: The Value of Cytopathology Combined with Molecular Analysis

Metastatic breast cancer (MBC) remains in most cases an incurable disease with genetic complexity and heterogeneity. Improvements in classification and management have been introduced, in addition to the development of endocrine and anti-HER2 targeted therapies. Currently, efforts are being made to...

Full description

Bibliographic Details
Main Authors: Ricella Souza da Silva, Fernando Schmitt
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Journal of Molecular Pathology
Subjects:
metastatic breast cancer
ancillary tests
fine needle aspiration
cytology
molecular biomarkers
Online Access:https://www.mdpi.com/2673-5261/3/4/28

Similar Items

Similar Items